Triclabendazole Tablet is considered safe and effective for human use when taken under medical supervision. It is an antiparasitic medication primarily used to treat fascioliasis, a liver fluke infection caused by Fasciola hepatica and Fasciola gigantica. The drug has been approved by the World Health Organization (WHO) and is included on the WHO Model List of Essential Medicines for treating this condition, which supports its safety profile when used appropriately.
Clinical studies and real-world use have shown that triclabendazole is generally well tolerated by most patients. The majority of side effects reported are mild to moderate and temporary. Common side effects may include abdominal pain, nausea, vomiting, headache, dizziness, fever, or fatigue. In many cases, these symptoms are linked not only to the drug itself but also to the body’s reaction as the parasites die and are eliminated.
Serious side effects are rare, but they can occur. Some individuals may experience allergic reactions or changes in liver enzyme levels. For this reason, triclabendazole should always be taken under the guidance of a healthcare professional, especially in patients with existing liver conditions.
Special caution is advised for pregnant and breastfeeding women. Although available data do not show strong evidence of harm, triclabendazole is usually prescribed during pregnancy only if the benefits clearly outweigh potential risks. A doctor’s evaluation is essential in such cases.
In conclusion, triclabendazole is safe for humans when used correctly and remains the treatment of choice for liver fluke infections. Proper diagnosis, correct dosing, and medical supervision are key to maximizing its benefits while minimizing risks.